ProKidney Corp. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ACLX
|
Arcellx, Inc. | $82.74 | $2.72 B | -49.3 | 130 | $110.32 M |
 ARVN
|
Arvinas, Inc. | $24.76 | $1.83 B | -4.41 | 445 | $78.50 M |
 BDTX
|
Black Diamond Therapeutics, Inc. | $4.24 | $291.95 M | -3.13 | 54 | $0 |
 CERE
|
Cerevel Therapeutics Holdings, Inc. | $44.96 | $7.29 B | -14.66 | 355 | $0 |
 DICE
|
DICE Therapeutics, Inc. | $47.55 | $2.27 B | -21.91 | 71 | $0 |
 ENOB
|
Enochian Biosciences, Inc. | $0.71 | $45.38 M | -0.34 | 22 | $0 |
 ERAS
|
Erasca, Inc. | $2.68 | $647.94 M | -2.83 | 126 | $0 |
 EWTX
|
Edgewise Therapeutics, Inc. | $26.07 | $1.65 B | -11.47 | 97 | $0 |
 GLUE
|
Monte Rosa Therapeutics, Inc. | $5.17 | $243.38 M | -1.59 | 129 | $0 |
 IMCR
|
Immunocore Holdings plc | $31.39 | $2.08 B | -26.72 | 497 | $249.43 M |
 KURA
|
Kura Oncology, Inc. | $19.51 | $1.66 B | -10.03 | 142 | $0 |
 LYEL
|
Lyell Immunopharma, Inc. | $1.50 | $619.50 M | -2.7 | 224 | $130,000 |
 MRUS
|
Merus N.V. | $47.76 | $3.50 B | -19.38 | 172 | $43.95 M |
 PCVX
|
Vaxcyte, Inc. | $113.14 | $7.72 B | -16.54 | 254 | $0 |
 PLRX
|
Pliant Therapeutics, Inc. | $11.32 | $672.63 M | -3.9 | 166 | $1.58 M |
 PMVP
|
PMV Pharmaceuticals, Inc. | $1.49 | $85.40 M | -1.26 | 63 | $0 |
 PTGX
|
Protagonist Therapeutics, Inc. | $44.54 | $2.04 B | 13.7 | 125 | $60.00 M |
 REPL
|
Replimune Group, Inc. | $11.16 | $485.18 M | -2.44 | 331 | $0 |
 RLAY
|
Relay Therapeutics, Inc. | $7.46 | $1.05 B | -3 | 304 | $25.55 M |
 RVMD
|
Revolution Medicines, Inc. | $44.15 | $6.66 B | -10.51 | 443 | $11.58 M |
 STOK
|
Stoke Therapeutics, Inc. | $12.23 | $774.50 M | -6.14 | 110 | $8.78 M |
 THRD
|
Third Harmonic Bio, Inc. | $13.48 | $581.89 M | -18.95 | 42 | $0 |
 VTYX
|
Ventyx Biosciences, Inc. | $2.31 | $229.83 M | -1.01 | 73 | $0 |